Telix Pharmaceuticals Limited

TLPPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$710,346$123,237$116,329$22,037
Short-Term Investments$0$0$0$0
Receivables$158,994$79,535$31,140$20,845
Inventory$38,144$17,310$5,767$3,454
Other Curr. Assets$11,080$4,766$57,188$1,207
Total Curr. Assets$918,564$224,848$173,233$47,543
Property Plant & Equip (Net)$54,321$30,493$18,838$6,329
Goodwill$106,647$4,847$5,519$4,097
Intangibles$309,487$104,816$58,984$55,729
Long-Term Investments$6,093$12,260-$5,519$0
Tax Assets$46,737$20,452$9,209$0
Other NC Assets$74,582$586$327-$3,885
Total NC Assets$597,867$173,454$87,358$62,270
Other Assets$0$0$0$0
Total Assets$1,516,431$398,302$260,591$109,813
Liabilities
Payables$68,698$32,837$16,806$11,884
Short-Term Debt$21,486$1,559$641$632
Tax Payable$48,577$11,508$7,320$0
Deferred Revenue$11,248$10,995$4,940$6,143
Other Curr. Liab.$180,903$100,509$55,849$19,323
Total Curr. Liab.$330,912$157,408$85,556$37,982
LT Debt$559,962$15,886$9,805$1,907
Deferred Rev, NC$3,288$12,162$22,522$23,056
Deferred Tax Liab, NC$9,381$3,920$5,238$0
Other NC Liab.$44,675$60,015$55,314$43,226
Total NC Liab.$617,306$91,983$92,879$68,189
Other Liabilities$0$0$0$0
Cap. Leases$10,637$8,272$7,134$2,520
Total Liabilities$948,218$249,391$175,346$106,171
Equity
Pref Stock$0$0$0$0
Common Stock$596,776$446,268$370,972$170,840
Retained Earnings-$212,962-$263,665-$272,815-$173,471
AOCI$184,399-$33,692-$18,150$4,789
Other Equity$0$0$0$0
Total Equity$568,213$148,911$80,007$2,158
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,516,431$398,302$255,353$109,813
Net Debt-$128,898-$105,792-$105,883-$19,498